Sovhi Health logoSovhi HealthTrack · Identify · Act
Science & Research

Why adolescence, and how we validate.

Scientific rationale

Adolescence is a sensitive period of brain development, with heightened plasticity that makes young people especially responsive to environmental influences such as social stress5. Sleep–wake timing shifts later at puberty and insufficient sleep is common and modifiable6; heavy social-media use is associated with poorer mental health, sleep and attention7; and half of lifetime mental disorders begin by age 141.

Most existing tools capture symptoms at a single point in time. Smartphone-based digital phenotyping now allows behavior to be measured passively and longitudinally in daily life8. A longitudinal measure that combines self-report with everyday signals can show how a young person is changing while patterns are still easy to shift.

Research questions
  • Do the MUDH-Adol ePRO’s two age-specific forms (12–17 and 18–25) and nine independently scored domains meet COSMIN standards for content validity, reliability and construct validity?
  • Do domain and overall scores change in expected directions with symptoms, functioning and global change over 12 weeks?
  • Do smartphone and wearable signals add information between self-report check-ins? (exploratory)
New ePRO in Development

MUDH-Adol™* electronic patient-reported outcome (ePRO): Advancing Personalized Growth Tracking and Preventive Health

A new adolescent-focused electronic patient-reported outcome (ePRO) measure designed to assess modifiable factors influencing growth, vitality, and well-being, enabling personalized insights, longitudinal tracking, and earlier opportunities for lifestyle support.

Youth (12–17) and Young Adult (18–25) forms of 30–40 items, with nine independently scored domains, each supported by clinical evidence linking it to healthy growth and vitality.

A new ePRO in development and currently seeking non-dilutive funding through NIH SBIR. First use will be in research and clinical settings.

Stress Load

Adolescent brains are highly plastic, so stress during these years can have lasting effects5, while positive coping is protective4.

Sleep and Recovery

Teens need 8–10 hours of sleep31; sufficient, regular sleep supports mood, learning and growth6.

Nutrition

Good-quality diets are consistently associated with better mental health in children and adolescents28.

Movement

Physical activity is a protective factor for adolescent mental health4, yet most U.S. adolescents fall short of activity guidelines30.

Social Connection

High family and school connectedness are associated with 48–66% lower odds of adult risk outcomes16,19.

Digital Wellness

More than 3 hours a day on social media is associated with more internalizing problems32; balanced use protects sleep and mood7.

Substance Use

Drugs such as cannabis have particularly harmful effects on the developing adolescent brain5.

Emotional Burden

Half of lifetime mental disorders begin by age 141, making early attention to emotional strain central to healthy development2.

Environmental Health

Exposure to green space is associated with reduced stress, more positive mood and fewer depressive symptoms in adolescents29.

*MUDH stands for Modifiable Drivers of Health.

Study design

High-level summary of our NIH SBIR Fast-Track proposal.

  • Purpose: COSMIN validation of a new psychometric instrument, the MUDH-Adol ePRO
  • Population: ages 12–25 in two cohorts, Youth (12–17) and Young Adult (18–25)
  • Participants: young people with and without elevated depressive or anxiety symptoms
  • Team: conducted with the Northwestern University psychometric expert team, developers of NIH PROMIS, under Sovhi’s Contact PD/PI
  • Goal: improve assessment of growth, vitality and modifiable drivers of health, to inform future lifestyle coaching and clinical interventions
  • Phase I (12 months): expert review, about 60 cognitive interviews and a 250-participant pilot with retest
  • Phase II (24 months): 600 completers followed for 12 weeks, plus an exploratory phone and wearable substudy in about 300
  • Standards: COSMIN and FDA patient-reported outcome guidance9,10

Validation criteria

PropertyPrespecified criterion
Content validityAt least 90% of retained items rated understandable and relevant; no new concepts in the final two interview waves
Structural validityOrdinal CFA supports the intended structure of each domain within each age form
ReliabilityOmega and test–retest ICC of at least 0.70
Construct validityAt least 75% of prespecified convergent, discriminant and known-groups hypotheses supported against PROMIS and domain-specific comparators, PHQ-A/PHQ-9 and GAD-7
ResponsivenessChange relates in the predicted direction to global-change, functioning and symptom anchors
Overall scoreClassified QUALIFY, REFINE or DO NOT RELEASE against prespecified criteria

Oversight

  • Northwestern University leads psychometrics, IRB oversight and study execution
  • Independent safety monitor or DSMB, plus a Medical Monitor and Site Clinical Lead
  • Certificate of Confidentiality; parental permission and assent for minors
  • Protocol, analysis plan and scoring locked and time-stamped before outcome analysis
Scope of the award

The study validates measurement. Participants continue usual care and receive no platform-generated recommendations. It does not establish diagnosis, treatment selection or clinical prediction.

All research and development is conducted in the United States. Full citations on the References page.